Skip to content
  • Saturday, 12 September 2026
  • 6:38 pm
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • High-Dose Fish Oil Supplements Fail to Slow Cognitive Decline in Older Adults at Risk for Alzheimer’s Disease Despite Successful Brain Penetration
Neuroscience & Brain Research

High-Dose Fish Oil Supplements Fail to Slow Cognitive Decline in Older Adults at Risk for Alzheimer’s Disease Despite Successful Brain Penetration

Rifan Muazin Jun 30, 2026 0

The multi-billion-dollar global industry built around omega-3 fatty acid supplements has faced a significant scientific setback following the release of…

Read More
Neuroscience & Brain Research

Exercise and Low-Dose Ibuprofen Show Promise in Mitigating Chemotherapy-Induced Cognitive Impairment

Rifan Muazin Jun 16, 2026 0

For decades, cancer survivors have reported a cloud of mental fog following treatment, a phenomenon colloquially termed "chemo brain." This…

Read More
Pharmaceutical R&D

UK Approves Lower Dose of Needle-Free Adrenaline Nasal Spray for Young Children

Teuku Ryan Jun 15, 2026 0

The United Kingdom’s Medicines and Healthcare products Regulatory Agency (MHRA) has granted approval for a new, lower dose of ALK-Abelló’s…

Read More
Pharmaceutical R&D

Novo Nordisk’s Wegovy Poised for Significant European Expansion Following Positive CHMP Opinions on Oral and High-Dose Injectable Formulations

Teuku Ryan May 27, 2026 0

The European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has delivered two pivotal positive opinions, paving…

Read More
Biotech Competition Spurs New Secretive Tactics and Shifts Investor ApproachRevolutionary Plant Wearables from Tufts University Promise a New Era of Precision AgricultureNew Qulipta Study Data Bolsters Case Against Restrictive European Reimbursement PoliciesTop 7 Coding Models You Can Run Locally in 2026
Japan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactMEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthThe Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals PlummetLLMOps in 2026: The 10 Tools Every Team Must Have
The oral exposure challenge in PROTACs: What drug developers need to solve earlyAttention Unleashed: Rethinking ADHD as a Conduit for Creative Innovation in the Modern Neurological LandscapeHarmonic Shielding: Harvard Researchers Use Microscopic Sound Waves to Protect Fragile Quantum InformationSolstice Oncology Secures $225m in Series A Financing to Advance Neoadjuvant Immuno-Oncology Therapy Porustobart
YOU MAY HAVE MISSED
Laboratory Automation & Robotics
The oral exposure challenge in PROTACs: What drug developers need to solve early
Lana Keisha Sep 12, 2026
Neuroscience & Brain Research
Attention Unleashed: Rethinking ADHD as a Conduit for Creative Innovation in the Modern Neurological Landscape
Rifan Muazin Sep 12, 2026
Advanced Materials Science
Harmonic Shielding: Harvard Researchers Use Microscopic Sound Waves to Protect Fragile Quantum Information
Nila Kartika Wati Sep 12, 2026
Pharmaceutical R&D
Solstice Oncology Secures $225m in Series A Financing to Advance Neoadjuvant Immuno-Oncology Therapy Porustobart
Teuku Ryan Sep 12, 2026

Copyright © 2025 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ